BioAtla (BCAB)
(Delayed Data from NSDQ)
$1.89 USD
+0.09 (5.00%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.89 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for BioAtla, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -123.46 | -106.48 | -95.40 | -35.85 | -29.86 |
Depreciation/Amortization & Depletion | 1.22 | 1.20 | 1.33 | 1.01 | 0.86 |
Net Change from Assets/Liabilities | 4.68 | 0.29 | 7.43 | -2.50 | 25.10 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.55 | 14.58 | 24.43 | 1.01 | -5.75 |
Net Cash From Operating Activities | -104.02 | -90.42 | -62.21 | -36.33 | -9.65 |
Property & Equipment | -0.10 | -0.27 | -0.92 | -0.59 | -1.51 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.10 | -0.27 | -0.92 | -0.59 | -1.51 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.34 | 61.97 | 71.42 | 268.39 | -0.01 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 2.75 | 4.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.68 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.26 | -0.76 | -1.91 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.08 | 61.21 | 69.51 | 271.83 | 4.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -104.04 | -29.47 | 6.37 | 234.90 | -7.16 |
Cash at Beginning of Period | 215.51 | 244.98 | 238.61 | 3.70 | 10.86 |
Cash at End of Period | 111.47 | 215.51 | 244.98 | 238.61 | 3.70 |
Diluted Net EPS | -2.58 | -2.74 | -2.76 | -4.25 | NA |
Fiscal Year End for BioAtla, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -44.31 | -23.23 | -123.46 | -96.54 | -63.21 |
Depreciation/Amortization & Depletion | 0.47 | 0.24 | 1.22 | 0.85 | 0.58 |
Net Change from Assets/Liabilities | -10.98 | -10.13 | 4.68 | 10.79 | 8.59 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.80 | 2.30 | 13.55 | 10.81 | 7.29 |
Net Cash From Operating Activities | -50.02 | -30.83 | -104.02 | -74.09 | -46.75 |
Property & Equipment | 0.00 | 0.00 | -0.10 | -0.09 | -0.07 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | -0.10 | -0.09 | -0.07 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.24 | 0.00 | 0.34 | 0.19 | 0.17 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.03 | -0.01 | -0.26 | -0.23 | -0.17 |
Net Cash from Financing Activities | 0.21 | -0.01 | 0.08 | -0.04 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -49.81 | -30.84 | -104.04 | -74.23 | -46.81 |
Cash at Beginning of Period | 111.47 | 111.47 | 215.51 | 215.51 | 215.51 |
Cash at End of Period | 61.66 | 80.63 | 111.47 | 141.28 | 168.69 |
Diluted Net EPS | -0.44 | -0.48 | -0.55 | -0.70 | -0.75 |